Recommended for circulatory diseases such as: risk of cerebral congestion (CVD), cerebral congestion with sequelae, angina pectoris, venous stagnation, thromboembolism, atherosclerosis, fibromyalgia, fatigue, intermittent claudication, retinal pathology, hypertension, diabetes, deep vein thrombosis.
Nattokinase was discovered by Japanese scientist Dr. Hiroyuki Sumi in 1998 by fermentation in the presence of the bacterium Bacillus subtilis natto.
Our diet contains a wide variety of foods that can lead to high cholesterol levels, deposits on the arteries and inflammation of the arteries. This creates an environment conducive to the formation of blood clots, cardiovascular disease and stroke. Atheromatous plaques are dangerous not only because they strangle blood flow but, in the worst case, they can become detached and circulate in the blood causing myocardial infarction or stroke (stroke).
The body produces certain substances that convert fibrinogen to fibrin. Fibrin contributes to the aggregation of platelets and red blood cells and the formation of thrombi. Blood clotting is useful when we get hurt because it helps close the wound. However, these clots often form where they should not, becoming a serious danger.
The enzyme that breaks down fibrin is plasmin. As we age, the body produces less and less plasmin and more fibrinogen caused by inflammation. As a result, the body begins to clot more blood and disintegrate less clotted blood.
Nattokinase has a unique ability to break down fibrin, even superior to plasmin. Nattokinase prevents blood clotting and plaque formation (atheroma) on the arteries. If blood clots do form, Nattokinase can dissolve them. This is extraordinary because it not only prevents the formation of unwanted clots but in cases of heart attack or stroke can dissolve the clot that clogs the affected artery helping to restore the bloodstream. Reaching the venous system, Nattokinase is also beneficial in cases of venous thrombosis.
A 2009 study concluded that Nattokinase may be beneficial in the catabolism of amyloid fibrils associated with Alzheimer’s disease.
Due to the ability of Nattokinase to dissolve amyloid fibrils, it may be an important element in the treatment of Multiple Sclerosis and Amyloid Lateral Sclerosis (ALS).
KONIG NATTOKINASE is encapsulated in delayed-dissolving (resistant to gastric acid) plant capsules to prevent the destruction of the enzyme by stomach acids.
Ingredients / capsule:
Each Delay Release vegetarian capsule contains:
| Nattokinase (from Soy / Glycine hispida) fermented with Bacillus subtilis natto | 100 mg / 2000 FU |
| Loading agent: microcrystalline cellulose | |
| Capsule: hydroxypropylmethylcellulose, gellan gum | |
| Antioxidant: ascorbyl palmitate | |
Does not contain: milk and dairy products, eggs, gluten, wheat, corn, yeasts, nuts, sweeteners, flavors, or artificial colors.
*FU = Fibrin dissolving Units
Synergistic combination with:
Studies show that Nattokinase reaches its maximum value in blood 12 hours after administration. In cases of high cardiovascular risk, and only with the consent of the specialist, 1 capsule can be administered every 12 hours to maintain a constant blood concentration for 24 hours.
EN
HU
ES
IT
